文献速递免疫规划卫生政策与健康促进传染病防控与疫情报告

建模为预防人狂犬病提供预防方案依据

Modelling to inform prophylaxis regimens to prevent human rabies.
PubMed 文献 · Vaccine · 2018-12-07

为支持SAGE议程,研究者建立模型比较狂犬病预防策略的相对成本与潜在效益,评估PEP方案、RIG给药方案及将PrEP纳入EPI。结果发现1周2位点皮内方案最具成本效益,RIG仅伤口给药可减少用量,PrEP纳入EPI比PEP加犬接种更昂贵。

要点

  • 1周2位点皮内PEP方案最具成本效益,可缓解疫苗短缺。
  • RIG应仅伤口给药,比剩余剂量远处肌注用量更少。
  • PrEP纳入EPI比PEP加犬接种更昂贵,仅极端情况考虑。

核心结论

  • 1周2位点皮内PEP方案成本更低且在疫苗短缺时可治疗更多患者。
  • RIG如可用应仅伤口给药。
  • PrEP极不可能高效利用资源,仅应在暴露发生率极高时考虑。

研究设计与样本

  • 建立模型比较狂犬病预防策略的相对成本与潜在效益,以支持SAGE议程。
  • 评估PEP方案、RIG给药方案及将PrEP纳入EPI。

主要发现

  • 皮内接种在所有场景下减少疫苗用量、成本更低并可能缓解短缺。
  • 1周2位点皮内方案最具成本效益,即使就诊咬伤患者少时亦如此。
  • RIG仅伤口给药比剩余剂量远处肌注用量显著更少。
  • PrEP纳入EPI比PEP加犬接种更昂贵。

关键数值与推荐

  • 1周2位点皮内方案被推荐,因成本更低且疫苗短缺时可治疗更多患者。
  • RIG如可用应仅伤口给药。
  • PrEP仅应在狂犬病暴露发生率极高时考虑。

临床怎么用

  • 优先采用1周2位点皮内PEP方案以降低成本并扩大治疗覆盖。
  • RIG如可用应仅伤口给药以减少用量。
  • PrEP不作为常规EPI项目,仅极端情况考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Strategic Advisory Group of Experts (SAGE) Working Group on rabies vaccines and immunoglobulins was established in 2016 to develop practical and feasible recommendations for prevention of human rabies. To support the SAGE agenda we developed models to compare the relative costs and potential benefits of rabies prevention strategies. METHODS: We examined Post-Exposure Prophylaxis (PEP) regimens, protocols for administration of Rabies Immunoglobulin (RIG) and inclusion of rabies Pre-Exposure Prophylaxis (PrEP) within the Expanded Programme on Immunization (EPI). For different PEP regimens, clinic throughputs and consumables for vaccine administration, we evaluated the cost per patient treated, costs to patients and potential to treat more patients given limited vaccine availability. RESULTS: We found that intradermal (ID) vaccination reduces the volume of vaccine used in all settings, is less costly and has potential to mitigate vaccine shortages. Specifically, the abridged 1-week 2-site ID regimen was the most cost-effective PEP regimen, even in settings with low numbers of bite patients presenting to clinics. We found advantages of administering RIG to the wound(s) only, using considerably less product than when the remaining dose is injected intramuscularly distant to the wound(s). We found that PrEP as part of the EPI programme would be substantially more expensive than use of PEP and dog vaccination in prevention of human rabies. CONCLUSIONS: These modeling insights inform WHO recommendations for use of human rabies vaccines and biologicals. Specifically, the 1-week 2-site ID regimen is recommended as it is less costly and treats many more patients when vaccine is in short supply. If available, RIG should be administered at the wound only. PrEP is highly unlikely to be an efficient use of resources and should therefore only be considered in extreme circumstances, where the incidence of rabies exposures is extremely high.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hampson K, Abela-Ridder B, Bharti O, et al. Modelling to inform prophylaxis regimens to prevent human rabies. Vaccine. 2018. PMID: 30528846. doi:10.1016/j.vaccine.2018.11.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。